Jonathan Goldman
MD
Associate Professor
👥Biography 个人简介
Jonathan Goldman at UCLA has contributed to small cell lung cancer clinical research including contributions to IMpower133 establishing atezolizumab plus platinum-etoposide as first-line standard for extensive-stage SCLC — the first new treatment to improve first-line SCLC survival in more than two decades. His work in thoracic oncology spanning SCLC and NSCLC has contributed to multiple important advances.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jonathan Goldman 的研究动态
Follow Jonathan Goldman's research updates
留下邮箱，当我们发布与 Jonathan Goldman（UCLA）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment